Donald Hayden

Donald Hayden

Vorstandsvorsitzender bei
WindMIL Therapeutics, Inc.
70 Jahre
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Donald J.
Hayden
is currently the Chairman & Chief Executive Officer at WindMIL Therapeutics, Inc. He is also the Chairman at Avanir Pharmaceuticals, Inc. and Otsuka America Pharmaceutical, Inc. Previously, he held various Chairman positions at Azelon Pharmaceuticals, Inc., Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Alvine Pharmaceuticals, Inc., REGENXBIO, Inc., Vitae Pharmaceuticals LLC, Transave, Inc., Insmed Ltd., Amicus Therapeutics, Inc., Cogentus Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Nora Therapeutics, Inc., and Dimension Therapeutics, Inc. He was also the Executive VP & President-Americas Region at Bristol Myers Squibb Co. and Vice President & GM-Mead Johnson Laboratories at Mead Johnson Nutrition Co. Additionally, he served as a Senior Advisor at Prospect Venture Partners.
He received his undergraduate degree from Harvard University and his MBA from Indiana University.

Aktive Positionen von Donald Hayden

UnternehmenPositionBeginn
Vorstandsvorsitzender 25.04.2019
Vorsitzender -

Ehemalige bekannte Positionen von Donald Hayden

UnternehmenPositionEnde
THESEUS PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 14.02.2024
REGENXBIO INC. Vorsitzender 01.07.2020
INSMED INCORPORATED Vorsitzender 08.11.2018
AMICUS THERAPEUTICS, INC. Vorsitzender 08.02.2010
VITAE PHARMACEUTICALS INC Vorsitzender 25.10.2016
Sehen Sie sich die Erfahrung von Donald Hayden im Detail an

Ausbildung von Donald Hayden

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

80

Beziehungen ersten Grades

23

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Donald Hayden